1 / 17

PPH Prevention through platform of antenatal care

PPH Prevention through platform of antenatal care. Albert Kitumbo, MD Ifakara Health Institute. Rationale for ANC Distribution of Misoprostol for Prevention of PPH. PPH is the leading cause of maternal death Misoprostol has been shown to be safe for preventing PPH at home deliveries

anthonymitchell
Download Presentation

PPH Prevention through platform of antenatal care

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PPH Prevention through platform of antenatal care Albert Kitumbo, MD Ifakara Health Institute

  2. Rationale for ANC Distribution of Misoprostol for Prevention of PPH • PPH is the leading cause of maternal death • Misoprostol has been shown to be safe for preventing PPH at home deliveries • In Tanzania: • 94% of women attend at least one antenatal care visit (ANC) during their pregnancy • 53% of women deliver outside of facilities By educating women and distributing misoprostol during ANC visits, women who deliver at home will have access to this life-saving technology

  3. Operations Research: Testing the ANC Distribution Model • Goal: Assess the feasibility, safety, program effectiveness, and acceptability of distribution of misoprostol through ANC visits • Conducted in 4 districts of Tanzania between January and December 2009 • Collaborating Institutions: Ifakara Health Institute; Venture Strategies Innovations; Bixby Center at the University of California, Berkeley Provide evidence that: • Women can safely self-administer misoprostol for prevention of PPH at home births • ANC visits are a feasible and effective means of distributing misoprostol for PPH prevention to women • Women and communities find misoprostol to be acceptable

  4. Components of the ANC Distribution Program • Community Awareness Campaign on Birth Preparedness and PPH Prevention • Radio • Community meetings with CORPs and TBAs • Posters and Pamphlets • Focused ANC with Misoprostol Distribution • ANC Visit • Education Session on PPH and Misoprostol • Misoprostol Distribution at > 32 weeks gestation Reduce PPH at Home Births

  5. Community Awareness Campaign Key messages: • Promote attendance at ANC throughout pregnancy • Importance of delivering in a health facility • Plan early for a safe delivery • PPH consequences & blood loss measurement with the kanga • Misoprostol is available at ANC once a woman is 32 weeks pregnant

  6. Focused ANC with Misoprostol Distribution • Educate all women coming to ANC about safe delivery and PPH prevention • Screen women for eligibility to receive misoprostol • Distribute misoprostol to eligible women > 32 weeks gestation

  7. Enrollment and ANC/Delivery Characteristics Enrollment • ANC Attendance = 12,892 • Enrollment = 12,511 (97%) • Postpartum Interview = 6,735 (54% of enrolled) ANC/Delivery Characteristics • Average number of ANC visits = 3.0 • ANC attendance > 32 weeks = 44% • Health facility delivery = 67%

  8. FeasibilityCoverage of Community Awareness Campaign

  9. Program EffectivenessComprehension of Campaign Messages PPH Information Misoprostol Information

  10. Program EffectivenessBirths Protected from PPH n= 6,735 Green color = Birth protected from PPH by use of uterotonic after delivery

  11. Program EffectivenessUse of Misoprostol by Location of Delivery Green color = Birth protected from PPH by use of uterotonic after delivery

  12. Need for Additional Interventions after Home Birth

  13. SafetyCorrect Use of Misoprostol Almost all 1,826 women who took misoprostol at home reported using the drug correctly: • Correct dose (3 tablets)= 99.5% • Correct route (oral) = 98%

  14. Women’s Acceptability

  15. Conclusions Integration of misoprostol into existing ANC Services is: • Feasible • Reach of community awareness campaign to almost all women • High enrollment and misoprostol distribution to eligible clients • Safe • All women used misoprostol correctly at home births • Low report of postpartum symptoms • Effective • High comprehension of key community awareness messages • 88% coverage of misoprostol at home births • Acceptable • Women feel more secure and protected from PPH

  16. Limitations and Challenges • Women returning for an ANC visit after 32 weeks gestation is lower than anticipated • Greater effort to encourage women to return to the health facility • In the future, consider lowering the gestational age requirement to receive misoprostol

  17. Policy Implications • Other countries with similarly high rates of ANC and lower rates of facility delivery should consider ANC distribution to protect women who deliver at home • All ANC providers should be trained to distribute misoprostol at ANC – bring the program to scale • Gestational age limitations decrease coverage – consider lower or removing • Scale up the community awareness campaign to increase knowledge of key messages • Consider other mechanisms of misoprostol distribution for self-administration • Misoprostol should be available in all delivery rooms

More Related